Published 2012 | Version v1.0.0
Journal Article Open
Fenfluramine Add-On Therapy of Dravet Syndrome
Researchers at Antwerp University Hospital and University of Leuven, Belgium report 12 patients, 7 female and 5 male, age range 3-35 years, with a genetically proven diagnosis of Dravet syndrome who received fenfluramine (mean dose 0.34 (0.12-0.90) mg/kg/day) as add-on therapy.
Files (101.0 kB)
||101.0 kB||Preview Download|
2012When the item was originally created.